Johnson & Johnson
NYSE-JNJ
Basic
Market Cap
$384.2B
EV
$391.62B
Shares Out
2,406.68M
Revenue
$86.58B
Employees
131,900
Margins
Gross
69.29%
EBITDA
35.98%
Operating
27.98%
Pre-Tax
22.53%
Net
43.91%
FCF
20.88%
Returns (5Yr Avg)
ROA
11.47%
ROTA
96.6%
ROE
30.06%
ROCE
17.57%
ROIC
16.18%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$170.67
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$26.22B
Net Debt
$7,414M
Debt/Equity
0.48
EBIT/Interest
31.38
Growth (CAGR)
Rev 3Yr
-0.99%
Rev 5Yr
1.26%
Rev 10Yr
1.67%
Dil EPS 3Yr
32.44%
Dil EPS 5Yr
20.73%
Dil EPS 10Yr
11.07%
Rev Fwd 2Yr
3.42%
EBITDA Fwd 2Yr
2.81%
EPS Fwd 2Yr
4.01%
EPS LT Growth Est
3.95%
Dividends
Yield
—
Payout
71.42%
DPS
$4.81
DPS Growth 3Yr
5.55%
DPS Growth 5Yr
5.67%
DPS Growth 10Yr
6.02%
DPS Growth Fwd 2Yr
4.52%
Select a metric from the list below to chart it
Dec '14
Jan '16
Jan '17
Dec '17
Dec '18
Dec '19
Jan '21
Jan '22
Jan '23
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)